2,500 Shares in Aflac Incorporated (NYSE:AFL) Purchased by Family Legacy Inc.

Family Legacy Inc. bought a new position in Aflac Incorporated (NYSE:AFL) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,500 shares of the financial services provider’s stock, valued at approximately $206,000.

Other large investors also recently modified their holdings of the company. Norges Bank bought a new stake in Aflac during the 4th quarter valued at approximately $175,416,000. Invesco Ltd. boosted its position in Aflac by 62.4% during the 1st quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock valued at $317,865,000 after acquiring an additional 1,897,212 shares in the last quarter. Morgan Stanley boosted its position in Aflac by 22.9% during the 4th quarter. Morgan Stanley now owns 8,812,956 shares of the financial services provider’s stock valued at $634,004,000 after acquiring an additional 1,640,984 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in Aflac during the 4th quarter valued at approximately $72,249,000. Finally, Barclays PLC boosted its position in shares of Aflac by 67.3% in the 2nd quarter. Barclays PLC now owns 1,712,568 shares of the financial services provider’s stock worth $119,539,000 after purchasing an additional 689,173 shares in the last quarter. 67.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on AFL. The Goldman Sachs Group boosted their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Morgan Stanley dropped their price target on Aflac from $85.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Friday, March 1st. Evercore ISI cut Aflac from an “in-line” rating to an “underperform” rating and boosted their price target for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Raymond James boosted their price target on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Finally, UBS Group boosted their price target on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Aflac presently has a consensus rating of “Hold” and an average price target of $80.36.

Aflac Stock Performance

AFL traded up $0.14 during mid-day trading on Tuesday, reaching $84.95. 1,661,607 shares of the company traded hands, compared to its average volume of 2,279,816. The stock has a market capitalization of $48.88 billion, a P/E ratio of 10.96, a P/E/G ratio of 2.30 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. The company’s fifty day moving average price is $81.61 and its 200-day moving average price is $80.67. Aflac Incorporated has a 52-week low of $62.93 and a 52-week high of $86.20.

Aflac (NYSE:AFL) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same quarter in the prior year, the firm posted $1.29 earnings per share. On average, sell-side analysts expect that Aflac Incorporated will post 6.43 EPS for the current year.

Insider Activity

In other news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Arthur Reginald Collins sold 3,000 shares of the company’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the completion of the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The disclosure for this sale can be found here. Insiders sold a total of 46,493 shares of company stock valued at $3,765,706 in the last 90 days. Company insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.